Learn More
Apexbio Technology LLC Tivantinib (ARQ 197), 5mg. Cas: 905854-02-6 MFCD: MFCD11977597. C-Met inhibitor,non-ATP-competitive

Supplier: Apexbio Technology LLC A83255
Tivantinib (ARQ 197) is an oral, nonadenosine triphosphate-competitive, selective, small-molecule met proto-oncogene (c-MET) inhibitor. The calculated inhibitory constant (Ki) for tivantinib to inhibit recombinant human c-MET was approximately 355 nmol/L. Other sizes are available. Please inqury us for quote.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.